BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3943595)

  • 1. Schistosoma mansoni: killing of transformed schistosomula by the alternative pathway of human complement.
    Marikovsky M; Levi-Schaffer F; Arnon R; Fishelson Z
    Exp Parasitol; 1986 Feb; 61(1):86-94. PubMed ID: 3943595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement regulation on the surface of cultured schistosomula and adult worms of Schistosoma mansoni.
    Marikovsky M; Parizade M; Arnon R; Fishelson Z
    Eur J Immunol; 1990 Jan; 20(1):221-7. PubMed ID: 2307175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteases secreted by transforming schistosomula of Schistosoma mansoni promote resistance to killing by complement.
    Marikovsky M; Arnon R; Fishelson Z
    J Immunol; 1988 Jul; 141(1):273-8. PubMed ID: 3132503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schistosoma mansoni: loss of the ability of schistosomula to bind mouse complement following intravenous injection into mice.
    Ruppel A; Rother U; Diesfeld HJ
    Tropenmed Parasitol; 1984 Mar; 35(1):23-8. PubMed ID: 6369693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation.
    Santoro F; Lachmann PJ; Capron A; Capron M
    J Immunol; 1979 Oct; 123(4):1551-7. PubMed ID: 113459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schistosoma mansoni: complement activation in human and rodent sera by living parasites of various developmental stages.
    Ruppel A; Rother U; Vongerichten H; Diesfeld HJ
    Parasitology; 1983 Aug; 87 (Pt 1)():75-86. PubMed ID: 6604899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of evasion of Schistosoma mansoni schistosomula to the lethal activity of complement.
    Ramalho-Pinto FJ; Carvalho EM; Horta MF
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():111-6. PubMed ID: 1285336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosoma mansoni: comparison of the killing effect of granulocytes and complement with or without antibody on fresh and cultured schistosomula in vitro.
    Novato-Silva E; Nogueira-Machado JA; Gazzinelli G
    Am J Trop Med Hyg; 1980 Nov; 29(6):1263-7. PubMed ID: 7446818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scanning electron microscopical observations on antigen-antibody coat formation on mechanically transformed Schistosoma mansoni schistosomula.
    Van der Linden PW; Koerten HK; Deelder AM
    Z Parasitenkd; 1982; 68(1):73-80. PubMed ID: 7136194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosoma japonicum and S. mansoni cercariae: different effects of protein in medium, of mechanical stress, and of an intact complement system on in vitro transformation to schistosomula.
    Wang W; Kirschfink M; Ruppel A
    Parasitol Res; 2006 Aug; 99(3):269-74. PubMed ID: 16547731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between Schistosoma mansoni and the complement system: role of IgG Fc peptides in the activation of the classical pathway by schistosomula.
    Ouaissi MA; Auriault C; Santoro F; Capron A
    J Immunol; 1981 Oct; 127(4):1556-9. PubMed ID: 7024409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cercarial glycocalyx of Schistosoma mansoni activates human complement.
    Samuelson JC; Caulfield JP
    Infect Immun; 1986 Jan; 51(1):181-6. PubMed ID: 3940995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decay accelerating factor (DAF) as the host antigen with protective activity to complement killing of schistosomula.
    Ramalho-Pinto FJ
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():213-6. PubMed ID: 2474124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of neutrophil- and eosinophil-mediated complement-dependent killing of schistosomula of Schistosoma mansoni in vitro by leukotriene B4.
    Moqbel R; Sass-Kuhn SP; Goetzl EJ; Kay AB
    Clin Exp Immunol; 1983 Jun; 52(3):519-27. PubMed ID: 6307558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schistosoma mansoni: evidence for a role of serum factors in protecting artificially transformed schistosomula against antibody-mediated killing in vitro.
    Tavares CA; Soares RC; Coelho PM; Gazzinelli G
    Parasitology; 1978 Oct; 77(2):225-43. PubMed ID: 704150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosoma mansoni: in vitro and in vivo killing of antibody-coated schistosomula.
    Correa-Oliveira R; Mota-Santos TA; Gazzinelli G
    Am J Trop Med Hyg; 1982 Sep; 31(5):991-8. PubMed ID: 7125066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosoma mansoni: activation of the alternative pathway of human complement by schistosomula.
    Dias Da Silva W; Kasatchkine MD
    Exp Parasitol; 1980 Oct; 50(2):278-86. PubMed ID: 7409076
    [No Abstract]   [Full Text] [Related]  

  • 18. Artificially transformed schistosomula of Schistosoma mansoni: mechanism of acquisition of protection against antibody-mediated killing.
    Tavares CA; Cordeiro MN; Mota-Santos TA; Gazzinelli G
    Parasitology; 1980 Feb; 80(1):95-104. PubMed ID: 6992062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schistosoma mansoni: ultrastructural damages due to complement on schistosomula in vitro.
    Ouaissi MA; Santoro F; Capron A
    Exp Parasitol; 1980 Aug; 50(1):74-82. PubMed ID: 7389860
    [No Abstract]   [Full Text] [Related]  

  • 20. Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils.
    Anwar AR; Smithers SR; Kay AB
    J Immunol; 1979 Feb; 122(2):628-37. PubMed ID: 762435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.